cIMP synthesized by sGC as a mediator of hypoxic contraction of coronary arteries

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 307, Issue 3, 2014, Pages

  Chen, Zhengju ^a   Zhang, Xu ^a,b   Ying, Lei ^c   Dou, Dou ^a,b   Li, Yanhui ^a,b   Bai, Yun ^a   Liu, Juan ^a   Liu, Limei ^a,b   Feng, Han ^a   Yu, Xiaoxing ^a   Leung, Susan Wai Sum ^d   Vanhoutte, Paul M ^d,e   Gao, Yuansheng ^a,b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c WENZHOU MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

^e UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Endothelium; Hypoxic vasoconstriction; Inosine 3 ,5 cyclic monophosphate; Soluble guanylyl cyclase

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; CYCLIC GMP; CYCLIC NUCLEOTIDE; DIETHYLENETRIAMINE; GUANYLATE CYCLASE; INOSINE 3',5' CYCLIC MONOPHOSPHATE; NITRIC OXIDE; RHO KINASE; UNCLASSIFIED DRUG; CELL RECEPTOR; CYCLIC IMP; ENZYME INHIBITOR; MYOSIN LIGHT CHAIN PHOSPHATASE; NITRIC OXIDE DONOR; SOLUBLE GUANYLYL CYCLASE; VASOCONSTRICTOR AGENT;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY ENDOTHELIUM; ARTICLE; BLOOD VESSEL REACTIVITY; CELL MEMBRANE PERMEABILITY; CORONARY ARTERY; CORONARY ARTERY CONSTRICTION; ENZYME PHOSPHORYLATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPOXIA; ISOLATED ARTERY; ISOMETRICS; NONHUMAN; PRIORITY JOURNAL; SYNTHESIS; TANDEM MASS SPECTROMETRY; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL HYPOXIA; CORONARY BLOOD VESSEL; DOSE RESPONSE; DRUG EFFECTS; ENZYME ACTIVATION; ENZYMOLOGY; METABOLISM; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SWINE; UPREGULATION; VASCULAR ENDOTHELIUM; VASOCONSTRICTION;

ANIMALS; CELL HYPOXIA; CORONARY VESSELS; CYCLIC IMP; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; ENZYME INHIBITORS; GUANYLATE CYCLASE; MYOSIN-LIGHT-CHAIN PHOSPHATASE; NITRIC OXIDE DONORS; PHOSPHORYLATION; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RHO-ASSOCIATED KINASES; SIGNAL TRANSDUCTION; SWINE; UP-REGULATION; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 84905267902     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00132.2014     Document Type: Article

References (33)

1. Ajani AE, Yan BP. The mystery of coronary artery spasm. Heart Lung Circ 16: 10-15, 2007.
2. Bähre H, Danker KY, Stasch JP, Kaever V, Seifert R. Nucleotidyl cyclase activity of soluble guanylyl cyclase in intact cells. Biochem Biophys Res Commun 443: 1195-1199, 2014.
3. Behmanesh M, Sakumi K, Abolhassani N, Toyokuni S, Oka S, Ohnishi YN, Tsuchimoto D, NakabeppuY. ITPase-deficient mice show growth retardation and die before weaning. Cell Death Differ 16: 1315-1322, 2009.
4. Beste KY, Burhenne H, Kaever V, Stasch JP, Seifert R. Nucleotidyl cyclase activity of soluble guanylyl cyclase α1β1. Biochemistry 51: 194-204, 2012.
5. Chan CK, Mak J, Gao Y, Man RY, Vanhoutte PM. Endotheliumderived NO, but not cyclic GMP, is required for hypoxic augmentation in isolated porcine coronary arteries. Am J Physiol Heart Circ Physiol 301: H2313-H2321, 2011.
6. Citterio-Quentin A, Salvi JP, Boulieu R. Determination of inosine triphosphate pyrophosphatase phenotype in human red blood cells using HPLC. Ther Drug Monit 34: 477-480, 2012.
7. De Mey JG, Vanhoutte PM. Heterogeneous behavior of the canine arterial and venous wall: importance of the endothelium. Circ Res 51: 439-447, 1982.
8. De Mey JG, Vanhoutte PM. Anoxia and endothelium-dependent reactivity of the canine femoral artery. J Physiol 335: 65-74, 1983.
9. Ferguson DR, Price RH. The production of cIMP by toad bladder, and its effects on transport of water and salt. FEBS Lett 34: 207-212, 1973.
10. Follmann M, Griebenow N, Hahn MG, Hartung I, Mais FJ, Mittendorf J, Schäfer M, Schirok H, Stasch JP, Stoll F, Straub A. The chemistry and biology of soluble guanylate cyclase stimulators and activators. Angew Chem Int Ed Engl 52: 9442-9462, 2013.
11. Friebe A, Koesling D. The function of NO-sensitive guanylyl cyclase: what we can learn from genetic mouse models. Nitric Oxide 21: 149-156, 2009.
12. Gao Y. The multiple actions of NO. Pflügers Arch 459: 829-839, 2010.
13. Gao Y, Portugal AD, Negash S, Zhou W, Longo LD, Raj JU. Role of Rho kinases in PKG-mediated relaxation of pulmonary arteries of fetal lambs exposed to chronic high altitude hypoxia. Am J Physiol Lung Cell Mol Physiol 292: L678-L684, 2007.
14. Garbers DL, Suddath JL, Hardman JG. Enzymatic formation of inosine 3', 5'-monophosphate and of 2'-deoxyguanosine 3', 5'-monophosphate. Inosinate and deoxyguanylate cyclase activity. Biochim Biophys Acta 377: 174-185, 1975.
15. Graeser T, Vanhoutte PM. Hypoxic contraction of canine coronary arteries: role of endothelium and cGMP. Am J Physiol Heart Circ Physiol 261: H1769-H1777, 1991.
16. Gribble FM, Loussouarn G, Tucker SJ, Zhao C, Nichols CG, Ashcroft FM. A novel method for measurement of submembrane ATP concentration. J Biol Chem 275: 30046-30049, 2000.
17. Guz A, Kurland GS, Freedberg AS. Relation of coronary flow to oxygen supply. Am J Physiol 199: 179-182, 1960.
18. Laughlin MH, Turk JR, Schrage WG, Woodman CR, Price EM. Influence of coronary artery diameter on eNOS protein content. Am J Physiol Heart Circ Physiol 284: H1307-H1312, 2003.
19. Li L, Zhou Y, Wang C, Zhao YL, Zhang ZG, Fan D, Cui XB, Wu LL. Src tyrosine kinase regulates angiotensin II-induced protein kinase C activation and proliferation in vascular smooth muscle cells. Peptides 31: 1159-1164, 2010.
20. Li RW, Yang C, Sit AS, Lin SY, Ho EY, Leung GP. Physiological and pharmacological roles of vascular nucleoside transporters. J Cardiovasc Pharmacol 59: 10-15, 2012.
21. Liu H, Chen Z, Liu J, Liu L, Gao Y, Dou D. Endothelium-independent hypoxic contraction of porcine coronary arteries may be mediated by activation of phosphoinositide 3-kinase/Akt pathway. Vasc Pharmacol 61: 56-62, 2014.
22. Nair X, Dyer DC. Effect of metabolic inhibitors and oxygen on responses of human umbilical arteries. Am J Physiol 225: 1118-1122, 1973.
23. Nuñez C, Victor VM, Martí M, D'Ocon P. Role of endothelial nitric oxide in pulmonary and systemic arteries during hypoxia. Nitric Oxide 37: 17-27, 2013.
24. Olivetti G, Melissari M, Marchetti G, Anversa P. Quantitative structural changes of the rat thoracic aorta in early spontaneous hypertension. Tissue composition, and hypertrophy and hyperplasia of smooth muscle cells. Circ Res 51: 19-26, 1982.
25. Pearson PJ, Lin PJ, Schaff HV, Vanhoutte PM. Augmented endothelium-dependent constriction to hypoxia early and late following reperfusion of the canine coronary artery. Clin Exp Pharmacol Physiol 23: 634-641, 1996.
26. Rubanyi GM, Vanhoutte PM. Hypoxia releases a vasoconstrictor substance from the canine vascular endothelium. J Physiol 364: 45-56, 1985.
27. Sakumi K, Abolhassani N, Behmanesh M, Iyama T, Tsuchimoto D, Nakabeppu Y. ITPA protein, an enzyme that eliminates deaminated purine nucleoside triphosphates in cells. Mutat Res 703: 43-50, 2010.
28. Shen J, Seye CI, Wang M, Weisman GA, Wilden PA, Sturek M. Cloning, up-regulation, and mitogenic role of porcine P2Y2 receptor in coronary artery smooth muscle cells. Mol Pharmacol 66: 1265-1274, 2004.
29. Simone PD, Pavlov YI, Borgstahl GE. ITPA (inosine triphosphate pyrophosphatase): from surveillance of nucleotide pools to human disease and pharmacogenetics. Mutat Res 753: 131-146, 2013.
30. 2 sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 83: 1325-1358, 2003.
31. Vanhoutte PM. Effects of anoxia and glucose depletion on isolated veins of the dog. Am J Physiol 230: 1261-1268, 1976.
32. Wolter S, Golombek M, Seifert R. Differential activation of cAMP-and cGMP-dependent protein kinases by cyclic purine and pyrimidine nucleotides. Biochem Biophys Res Commun 415: 563-566, 2011.
33. Ying L, Xu X, Liu J, Dou D, Yu X, Ye L, He Q, Gao Y. Heterogeneity in relaxation of different sized porcine coronary arteries to nitrovasodilators: role of PKG and MYPT1. Pflügers Arch 463: 257-268, 2012.